Similar to other studies, while CRP/Alb was a significant predictor of OS in patients with ovarian cancer, residual tumor mass and tumor stage remained significantly more powerful predictors of survival, as the Hazard Ratio for residual tumor and tumor stage were 2.337 and 1.577, respectively, compared with the HR of 1.330 for CRP/Alb by multivariate analysis. The gene discussed is ALB; the disease is neoplasm.